Narrow search
Showing 21 - 30 of 35,867
Cover Image
Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphom...
Uyl-de Groot, Carin A.; Ossenkoppele, Gert J.; Buijt, Ivanne - In: PharmacoEconomics 15 (1999) 3, pp. 305-311
Objective: The aim of this paper is to compare the costs of autologous bone marrow transplantation (ABMT) and whole blood transplantation in patients with relapsed or poorly responding non-Hodgkin's lymphoma. Design and setting: In a retrospective study, we calculated the treatment costs of 40...
Persistent link: https://www.econbiz.de/10005449312
Cover Image
The Effectiveness of An Interactive Electronic Lung Function Monitoring System in the Total Management of Refractory Asthma
Doherty, Grace Baldwin; Ross, Robert N.; Ross, Phyllis E. - In: Disease Management and Health Outcomes 3 (1998) 2, pp. 89-98
A hand-held interactive electronic lung function device and tele-health monitoring system (AirWatch(TM) Airway Monitoring System, ENACT Health Management Systems, Inc., Mountain View, California, USA) has been developed that measures, records and reports airway status via a remote computer to...
Persistent link: https://www.econbiz.de/10005404660
Cover Image
Predicting Hospitalisation of Patients with Diabetes Mellitus: An Application of the Bayesian Discriminant Analysis
Bhattacharyya, Samir K. - In: PharmacoEconomics 13 (1998) 5, pp. 519-529
identifying both the personal and the healthcare system characteristics predictive of hospitalisation for the treatment of … probability of one or more hospitalisation events among patients with diabetes. The study used claims data extracted from the … predictive of 1 or more hospitalisation events. The model shows a predictive power of almost 90%. This study found that …
Persistent link: https://www.econbiz.de/10005404891
Cover Image
Hospital Length of Stay for Schizophrenia: Is Primary Payer an Influencing Factor?
Sclar, David A.; Robison, Linda M.; Skaer, Tracy L.; … - In: Disease Management and Health Outcomes 5 (1999) 6, pp. 339-347
schizophrenia and requiring a hospitalisation in the calendar year 1988 or 1992, by primary payer type (Medicare; Medicaid; or …
Persistent link: https://www.econbiz.de/10005590212
Cover Image
Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections
Holliday, Stephen M.; Benfield, Paul - In: PharmacoEconomics 13 (1998) 3, pp. 359-377
Meropenem is a carbapenem antibiotic which is active against the majority of aerobic and anaerobic bacteria implicated in serious infections. Its therapeutic efficacy in a wide range of serious infections is similar to that of imipenem/cilastatin and standard combination drug regimens. Hence,...
Persistent link: https://www.econbiz.de/10005590296
Cover Image
Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System
Postma, M.; Oenema, Dettie; Terpstra, Symon; Bouma, Jelte; … - In: PharmacoEconomics 15 (1999) 4, pp. 395-404
of the pump and related hospitalisation days. The total costs of patient selection, testing, implanting the pump and …) can be attributed mostly to implantation of the pump and related hospitalisation days. Savings originated from withdrawal …
Persistent link: https://www.econbiz.de/10005590444
Cover Image
Costs Associated with Symptomatic Systolic Heart Failure
Davey, Peter G.; Clarkson, Peter B.; McMahon, Alex; … - In: PharmacoEconomics 16 (1999) 4, pp. 399-407
Objective: To investigate whether the extent of systolic dysfunction is a useful predictor of the costs of healthcare and social support for patients with heart failure. Design: Cross-sectional study with collection of cost data attributed to management of heart failure in the previous year....
Persistent link: https://www.econbiz.de/10005590477
Cover Image
Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany
Schadlich, Peter K.; Paschen, Britta; Brecht, Josef Georg - In: PharmacoEconomics 13 (1998) 1 Part 2, pp. 147-155
The Cardiac Insufficiency Bisoprolol Study (CIBIS) demonstrates that, for patients with heart failure of different aetiologies, administration of the beta1-adrenoceptor blocker bisoprolol as an adjuvant to the standard therapy leads to a significant avoidance of hospital admissions. A...
Persistent link: https://www.econbiz.de/10005590513
Cover Image
Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
Eaddy, Michael; Seal, Brian; Tangirala, Krishna; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 431-440
Background:Background: Rasburicase is a recombinant urate-oxidase enzyme used to reduce high levels of plasma uric acid (PUA) resulting from tumour lysis syndrome (TLS). Rasburicase reduces PUA levels within 4 hours of administration, thereby minimizing the risk of serious complications from...
Persistent link: https://www.econbiz.de/10010585887
Cover Image
Impact of Treatment Success on Health Service Use and Cost in Depression: Longitudinal Database Analysis
Byford, Sarah; Barrett, Barbara; Despiégel, Nicolas … - In: PharmacoEconomics 29 (2011) 2, pp. 157-170
Background: Research has consistently demonstrated a relationship between depression and increased levels of health service use over the short term. However, much less is known about how this relationship is influenced by the success, or otherwise, of depression management strategies, and the...
Persistent link: https://www.econbiz.de/10011005073